再鼎医药盘中异动快速拉升5.04%

市场透视2025-03-04

北京时间2025年03月04日22时39分，再鼎医药（ZLAB.us）股票出现异动，股价大幅上涨5.04%。截至发稿，该股报33.33美元/股，成交量13.911万股，换手率0.13%，振幅5.48%。最近的财报数据显示，该股实现营业收入3.99亿美元，净利润-2.57亿美元，每股收益-2.60美元，毛利2.51亿美元，市盈率-12.80倍。机构评级方面，在所有12家参与评级的机构中，83%的券商...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2516775746?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-04 22:39","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2516775746","market":"us","top_or_hot":-1,"title":"再鼎医药盘中异动 快速拉升5.04%","media":"市场透视","content":"<div>\n<p>北京时间2025年03月04日22时39分，再鼎医药（ZLAB.us）股票出现异动，股价大幅上涨5.04%。截至发稿，该股报33.33美元/股，成交量13.911万股，换手率0.13%，振幅5.48%。最近的财报数据显示，该股实现营业收入3.99亿美元，净利润-2.57亿美元，每股收益-2.60美元，毛利2.51亿美元，市盈率-12.80倍。机构评级方面，在所有12家参与评级的机构中，83%的券商...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223917989bae72&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>再鼎医药盘中异动 快速拉升5.04%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n再鼎医药盘中异动 快速拉升5.04%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-04 22:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223917989bae72&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年03月04日22时39分，再鼎医药（ZLAB.us）股票出现异动，股价大幅上涨5.04%。截至发稿，该股报33.33美元/股，成交量13.911万股，换手率0.13%，振幅5.48%。最近的财报数据显示，该股实现营业收入3.99亿美元，净利润-2.57亿美元，每股收益-2.60美元，毛利2.51亿美元，市盈率-12.80倍。机构评级方面，在所有12家参与评级的机构中，83%的券商...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223917989bae72&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223917989bae72&s=b","article_id":"2516775746","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223917989bae72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2516775746","pubTimestamp":1741099157,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年03月04日22时39分，再鼎医药股票出现异动，股价大幅上涨5.04%。再鼎医药股票所在的生物技术行业中，整体涨幅为0.12%。】高盛发表研究报告指出，再鼎医药 2024 年第四季收入按年增长 66%至 1.085 亿美元，符合该行预期的 1.08 亿美元，各项产品收入表现均符合预测。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4585":"ETF&股票定投概念","ZLAB":"再鼎医药","BK4548":"巴美列捷福持仓","BK4588":"碎股","BK4139":"生物科技","BK4531":"中概回港概念","BK4526":"热门中概股"},"translate_title":"Zai Lab's intraday changes rose rapidly by 5.04%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZLAB":1},"content_text":"北京时间2025年03月04日22时39分，再鼎医药（ZLAB.us）股票出现异动，股价大幅上涨5.04%。截至发稿，该股报33.33美元/股，成交量13.911万股，换手率0.13%，振幅5.48%。最近的财报数据显示，该股实现营业收入3.99亿美元，净利润-2.57亿美元，每股收益-2.60美元，毛利2.51亿美元，市盈率-12.80倍。机构评级方面，在所有12家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。再鼎医药股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1105.81%、1097.19%、431.48%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 (To Pur Com)、Hepion Pharmaceuticals, Inc.、Windtree Therapeutics, Inc.，振幅分别为37.67%、22.25%、19.21%。再鼎医药公司简介：再鼎医药有限公司是一家生物制药公司，专注于发现或许可、开发和商业化专利疗法，以解决未满足的医疗需求领域，包括肿瘤、自身免疫和传染病领域。 该公司的专利候选药物管线包括：ZL-2306，用于治疗包括卵巢癌和某些类型的乳腺癌和肺癌在内的多种实体瘤类型； ZL-2401，一类新型四环素衍生物中的抗生素； ZL-2301，一种靶向HCC的口服小分子药物。消息层面，截至22时39分，《再鼎医药：25 年或成里程碑，评级买入》资讯为影响再鼎医药的重要信息。该信息摘要如下：【3 月 3 日，高盛称再鼎医药 2024 年第四季销售表现符合预期。】高盛发表研究报告指出，再鼎医药 2024 年第四季收入按年增长 66%至 1.085 亿美元，符合该行预期的 1.08 亿美元，各项产品收入表现均符合预测。该行重申 2025 年是再鼎医药发展里程碑年，亏损预期持续收窄，预计今年第四季可实现盈利，关注 bemarituzumab、TIVDAK 及 Optune 等产品的新药上市申请进展，并给予“买入”评级，H 股目标价从 40.4 港元上调至 42.01 港元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2516775746","isCrawlerRequest":true}

再鼎医药盘中异动 快速拉升5.04%

精彩评论

再鼎医药盘中异动快速拉升5.04%